Thalidomide Therapy for Very Early Onset Inflammatory Bowel Disease
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
This is a single center, observational study to investigate the clinical outcomes of thalidomide treatment for very early onset inflammatory bowel disease
Eligibility
Participation Requirements
Sex: All
Minimum Age: 28 days
Maximum Age: 6
Healthy Volunteers: f
View:
• diagnosed with inflammatory bowel disease
• disease onset less than 6 years old
• Pediatric Crohn's disease Activity Index (PCDAI)\>30 or Pediatric Ulcerative Colitis Activity Index (PUCAI)\>35
• patients and their legal guardians were willing to receive thalidomide treatment and participate in this study.
Locations
Other Locations
China
Lin Wang
RECRUITING
Shanghai
Contact Information
Primary
Ying Huang
yhuang815@163.com
021-64931727
Time Frame
Start Date: 2024-05-15
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 40
Related Therapeutic Areas
Sponsors
Leads: Children's Hospital of Fudan University